Bayer AG (BAYRY) (Q3 2026) Earnings Call Highlights: Raised Full-Year Outlook on Pharma ...
Bayer AG (BAYRY) lifted its 2026 adjusted EBITDA, free cash flow and net debt guidance as Nubeqa and Kerendia momentum offset Crop Science and Consumer Health headwinds. Related Stocks: BAYRY ,